APA ציטוט

Axelsson, S., Magnuson, A., Lange, A., Alshamari, A., Hörnquist, E. H., & Hultgren, O. (2020). A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex. BMC Immunol.

Citação norma Chicago

Axelsson, Susanne, Anders Magnuson, Anna Lange, Aseel Alshamari, Elisabeth Hultgren Hörnquist, and Olof Hultgren. "A Combination of the Activation Marker CD86 and the Immune Checkpoint Marker B and T Lymphocyte Attenuator (BTLA) Indicates a Putative Permissive Activation State of B Cell Subtypes in Healthy Blood Donors Independent of Age and Sex." BMC Immunol 2020.

ציטוט MLA

Axelsson, Susanne, et al. "A Combination of the Activation Marker CD86 and the Immune Checkpoint Marker B and T Lymphocyte Attenuator (BTLA) Indicates a Putative Permissive Activation State of B Cell Subtypes in Healthy Blood Donors Independent of Age and Sex." BMC Immunol 2020.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.